Skip to main content
. 2024 Feb 14;147(1):40. doi: 10.1007/s00401-024-02691-4

Fig. 3.

Fig. 3

Immunohistochemical distinction between MOAB-2 labelled Aβ and APP immunoreactivity in the frontal cortex of an AD case. Example micrographs of APP (N-terminal-APP antibody) and Aβ (MOAB-2) from an AD case, in the grey (GM; a) and white matter (WM; b). Note the distinctive labelling of subcellular pools within insert and differential labelling of plaques (in a) Scale = 20 µm